S. 1000 118th Congress
Saving Access to Laboratory Services Act
Latest action, Mar 28, 2023: Read twice and referred to the Committee on Finance.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
5 cosponsors
Sponsored by Sherrod Brown (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
2 D · 3 R
- Democrat
- Republican
- Independent
Referred to: Senate: Finance Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
8 reports
AMERICAN MEDICAL TECHNOLOGISTS
MICHAEL N. MCCARTY LAW OFFICE PLLC
8 reports
LABORATORY CORPORATION OF AMERICA HOLDINGS
KELLEY DRYE & WARREN LLP
8 reports
POINT OF CARE TESTING ASSOCIATION
MCDERMOTT+ LLC
8 reports
8 reports
ROCHE DIAGNOSTICS CORPORATION
HOOPER, LUNDY & BOOKMAN, P.C.
8 reports
8 reports
7 reports
7 reports
AMERICAN SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS
WHEAT SHROYER GOVERNMENT RELATIONS LLC
7 reports
QUEST DIAGNOSTICS INCORPORATED
FEDERAL STREET STRATEGIES, LLC
7 reports
6 reports
HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS)
GOVERNMENT COUNSEL, LLC
6 reports
All 25 of 35 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| AMERICAN CLINICAL LABORATORY ASSN | 8 | $4.2M | Q1 2023 | Q3 2024 | yes | |
| AMERICAN MEDICAL TECHNOLOGISTS | MICHAEL N. MCCARTY LAW OFFICE PLLC | 8 | $80K | Q1 2023 | Q3 2024 | yes |
| F HOFFMANN-LA ROCHE LTD AND ITS AFFILIATES | 8 | $1.0M | Q1 2023 | Q3 2024 | yes | |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | KELLEY DRYE & WARREN LLP | 8 | $0 | Q1 2023 | Q3 2024 | yes |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | 8 | $3.7M | Q1 2023 | Q3 2024 | yes | |
| POINT OF CARE TESTING ASSOCIATION | MCDERMOTT+ LLC | 8 | $240K | Q1 2023 | Q3 2024 | yes |
| QUEST DIAGNOSTICS INCORPORATED | 8 | $3.9M | Q1 2023 | Q3 2024 | yes | |
| ROCHE DIAGNOSTICS CORPORATION | HOOPER, LUNDY & BOOKMAN, P.C. | 8 | $270K | Q1 2023 | Q3 2024 | yes |
| THERMO FISHER SCIENTIFIC INC | 8 | $4.0M | Q1 2023 | Q3 2024 | yes | |
| ABBOTT LABORATORIES | 7 | $7.2M | Q4 2023 | Q3 2024 | yes | |
| ADVANCED MEDICAL TECHNOLOGY ASSN | 7 | $5.9M | Q4 2023 | Q3 2024 | yes | |
| AMERICAN SOCIETY FOR HISTOCOMPATIBILITY AND IMMUNOGENETICS | WHEAT SHROYER GOVERNMENT RELATIONS LLC | 7 | $140K | Q4 2023 | Q3 2024 | yes |
| QUEST DIAGNOSTICS INCORPORATED | FEDERAL STREET STRATEGIES, LLC | 7 | $0 | Q4 2023 | Q3 2024 | yes |
| COLLEGE OF AMERICAN PATHOLOGISTS | 6 | $1.0M | Q4 2023 | Q3 2024 | yes | |
| HOOPER,LUNDY& BOOKMAN, PC (OBO ROCHE DIAGNOSTICS) | GOVERNMENT COUNSEL, LLC | 6 | $70K | Q4 2023 | Q3 2024 | yes |
| AMERICAN CLINICAL LABORATORY ASSOCIATION | KOUNTOUPES DENHAM CARR & REID, LLC | 5 | $350K | Q4 2023 | Q3 2024 | yes |
| AMERICAN SOCIETY FOR MICROBIOLOGY | 5 | $250K | Q4 2023 | Q3 2024 | yes | |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 5 | $3.1M | Q4 2023 | Q3 2024 | yes | |
| ADVION (FORMERLY NATIONAL ASSOCIATION FOR THE SUPPORT OF LONG TERM CARE) | 4 | $345K | Q1 2024 | Q3 2024 | yes | |
| AMERICAN ASSOCIATION OF BIOANALYSTS | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 4 | $280K | Q1 2024 | Q3 2024 | yes |
| BIOREFERENCE LABORATORIES AN OPKO HEALTH COMPANY | JD LISS ASSOCIATES FORMERLY KNOWN AS JONATHAN DAVID LISS | 4 | $100K | Q1 2023 | Q3 2023 | yes |
| AMERICAN MEDICAL ASSOCIATION | 3 | $13.9M | Q4 2023 | Q3 2023 | yes | |
| ASSOCIATION FOR DIAGNOSTICS & LABORATORY MEDICINE (FORMERLY AACC) | 3 | $380K | Q2 2023 | Q2 2024 | yes | |
| ASSOCIATION FOR MOLECULAR PATHOLOGY | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 3 | $60K | Q4 2023 | Q3 2023 | yes |
| HEALTHCARE INSTITUTE OF NEW JERSEY | 3 | $183K | Q4 2023 | Q3 2023 | yes |